The phase IIb SYMMETRY study evaluated two doses of EFX (28mg and 50mg) compared with a placebo ... is also evaluating its blockbuster GLP-1 therapy, semaglutide, for MASH. In late 2024, Novo ...

Shares of Akero Therapeutics AKRO skyrocketed 105.7% in a week after the company announced initial positive top line 96-week data from a mid-stage study of its lead product candidate, efruxifermin ...

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

Semaglutide could help people drink less alcohol. Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help people drink less ...

Plus, check out our handy semaglutide weight loss dosage chart for an easy-to-follow overview of what to expect. Semaglutide is the active ingredient in three medications approved by the U.S. Food ...

Is Compounded Semaglutide Effective for Weight Loss ... Perhaps patients who can’t swallow need a liquid version of a tablet medication, or someone with an allergy needs a dye removed.

In May 2023, the company reported positive outcomes from its OASIS 1 Phase IIIa trial of oral semaglutide 50mg, which achieved its primary endpoint of improved weight loss at week 68 in obese or ...

Kidney disease treatment is undergoing a transformation, driven by exciting new research that reveals the protective power of semaglutide in patients with type 2 diabetes. Semaglutide, a ...

Health Canada has issued a recall notice for compounded drugs containing semaglutide, which is a key component in popular medications like Ozempic and Wegovy. The notice was issued on Tuesday ...